欧狄沃-话题@MedSci

#欧狄沃#

25篇内容 | 1830人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1376931, encodeId=532e13e69313c, content=<a href='/topic/show?id=4df06311110' target=_blank style='color:#2F92EE;'>#欧狄沃#</a>, objectTitle=百时美施贵宝公布欧狄沃®（nivolumab，纳武利尤单抗注射液）用于晚期经治非小细胞肺癌患者汇总五年总生存（OS）数据, objectType=article, longId=179251, objectId=fc171e9251bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc171e9251bb, replyNumber=0, likeNumber=57, createdTime=2019-09-12, rootId=0, userName=charl1234567, userId=62a7397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc171e9251bb, moduleTitle=百时美施贵宝公布欧狄沃®（nivolumab，纳武利尤单抗注射液）用于晚期经治非小细胞肺癌患者汇总五年总生存（OS）数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc171e9251bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1376930, encodeId=bf7413e6930dc, content=<a href='/topic/show?id=4df06311110' target=_blank style='color:#2F92EE;'>#欧狄沃#</a>, objectTitle=百时美施贵宝公布欧狄沃（纳武利尤单抗注射液）治疗经治非小细胞肺癌患者的长期生存汇总分析结果, objectType=article, longId=163563, objectId=b02416356319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b02416356319, replyNumber=0, likeNumber=66, createdTime=2019-04-05, rootId=0, userName=charl1234567, userId=62a7397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b02416356319, moduleTitle=百时美施贵宝公布欧狄沃（纳武利尤单抗注射液）治疗经治非小细胞肺癌患者的长期生存汇总分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b02416356319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1376929, encodeId=75f213e6929e6, content=<a href='/topic/show?id=4df06311110' target=_blank style='color:#2F92EE;'>#欧狄沃#</a>, objectTitle=国内上市PD-1抗癌药欧狄沃价格披露，比国外便宜近半, objectType=article, longId=147258, objectId=92bb14e2587c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92bb14e2587c, replyNumber=0, likeNumber=53, createdTime=2018-08-24, rootId=0, userName=charl1234567, userId=62a7397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92bb14e2587c, moduleTitle=国内上市PD-1抗癌药欧狄沃价格披露，比国外便宜近半, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92bb14e2587c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1376928, encodeId=5cfe13e6928f6, content=<a href='/topic/show?id=4df06311110' target=_blank style='color:#2F92EE;'>#欧狄沃#</a>, objectTitle=定了！欧狄沃定价9260RMB（100mg），28日将在中国多城市开售, objectType=article, longId=147083, objectId=df4b14e0830e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df4b14e0830e, replyNumber=0, likeNumber=50, createdTime=2018-08-22, rootId=0, userName=charl1234567, userId=62a7397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df4b14e0830e, moduleTitle=定了！欧狄沃定价9260RMB（100mg），28日将在中国多城市开售, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df4b14e0830e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1376927, encodeId=ebed13e6927ad, content=<a href='/topic/show?id=4df06311110' target=_blank style='color:#2F92EE;'>#欧狄沃#</a>, objectTitle=百时美施贵宝欧狄沃™三季度即将登陆中国, objectType=article, longId=146555, objectId=bf9c1465557e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf9c1465557e, replyNumber=0, likeNumber=77, createdTime=2018-08-15, rootId=0, userName=charl1234567, userId=62a7397, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf9c1465557e, moduleTitle=百时美施贵宝欧狄沃™三季度即将登陆中国, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf9c1465557e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

欧狄沃

2020-05-29

charl1234567 (审核中...)

前往app查看评论内容

#欧狄沃#

百时美施贵宝公布欧狄沃®（nivolumab，纳武利尤单抗注射液）用于晚期经治非小细胞肺癌患者汇总五年总生存（OS）数据

2019-09-12

charl1234567 (审核中...)

前往app查看评论内容

#欧狄沃#

百时美施贵宝公布欧狄沃（纳武利尤单抗注射液）治疗经治非小细胞肺癌患者的长期生存汇总分析结果

2019-04-05

charl1234567 (审核中...)

前往app查看评论内容

#欧狄沃#

国内上市PD-1抗癌药欧狄沃价格披露，比国外便宜近半

2018-08-24

charl1234567 (审核中...)

前往app查看评论内容

#欧狄沃#

定了！欧狄沃定价9260RMB（100mg），28日将在中国多城市开售

2018-08-22

charl1234567 (审核中...)

前往app查看评论内容

#欧狄沃#

百时美施贵宝欧狄沃™三季度即将登陆中国

2018-08-15

科室
- - 订阅+
  - 更多科室
工具
服务